RVPH
NASDAQ · Pharmaceuticals
Reviva Pharmaceuticals Holdi
$0.88
+0.01 (+1.08%)
Open$0.87
Previous Close$0.87
Day High$0.91
Day Low$0.85
52W High$23.20
52W Low$0.59
Volume—
Avg Volume297.2K
Market Cap11.05M
P/E Ratio—
EPS$-6.74
SectorPharmaceuticals
Analyst Ratings
Strong Buy
12 analysts
Price Target
+1,305.8% upside
Current
$0.88
$0.88
Target
$12.37
$12.37
$10.29
$12.37 avg
$18.62
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 8.36M | 8.56M | 9.00M |
| Net Income | 1.57M | 1.65M | 1.70M |
| Profit Margin | 18.8% | 19.3% | 18.9% |
| EBITDA | 1.64M | 1.79M | 2.00M |
| Free Cash Flow | 1.45M | 1.55M | 1.35M |
| Rev Growth | +3.9% | +2.6% | +16.0% |
| Debt/Equity | 0.31 | 0.31 | 0.40 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |